3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ulcer
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Sarcoma, Kaposi
1
Sarcoma
1
Ovarian Neoplasms
1
Lymphatic Metastasis
1
Hemangioma, Capillary
1
Fallopian Tube Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Gemcitabine
16
Cisplatin
14
pembrolizumab
10
durvalumab
10
Oxaliplatin
8
Magnetic Resonance Spectroscopy
8
Specimen Handling
6
Leucovorin
6
Biopsy
6
Fluorouracil
5
Paclitaxel
4
Folfox protocol
4
fludarabine
3
Taxes
3
Radiation
3
Nivolumab
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
tislelizumab
2
pemigatinib
2
olaparib
2
lenvatinib
2
futibatinib
2
dehydroftorafur
2
S 1 (combination)
2
Platinum
2
Liver Transplantation
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Propranolol
×
90 days
×
Clear all
No trials found.